The Board at its meeting held today, May 14, 2026, had declared Interim Dividend of INR.4.00 (200%) per equity share for the FY 2025-26 and fixed the Record date as May 30, 2026.
CAPLIPOINT · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Caplin Point Laboratories declared an interim dividend of INR 4.00 (200%) per equity share of face value INR 2 each for FY 2025-26. The record date for determining shareholder eligibility is May 30, 2026. For FY26, consolidated revenue grew 13.2% YoY to ₹2,303 Crores, while PAT increased 20.1% to ₹650 Crores. US market revenue surged 28.7% to ₹471 Crores. The company maintains strong liquidity with ₹1,471 Crores in free cash reserves and ₹2,726 Crores in liquid assets. The standalone PAT for FY26 stood at ₹396.58 Crores. Auditors issued unmodified opinions on both standalone and consolidated financial statements.
The 200% interim dividend signals strong cash generation and confidence in business performance. Shareholders on record as of May 30, 2026 will receive ₹4 per share. The robust 20% PAT growth and expanding US business are positive indicators for investors.